Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    9166827 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
Conditions: Lymphoma;   Diffuse Large Cell
Intervention: Procedure: Blood draw
2 Recruiting BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)
Condition: Follicular Lymphoma
Intervention: Drug: BeEAM
3 Active, not recruiting Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas
Condition: Lymphoma
Interventions: Procedure: Electrocardiogram;   Procedure: Urine tests;   Procedure: Blood Tests;   Procedure: MRI

Indicates status has not been verified in more than two years